Merck settles a marketing lawsuit for $5.9 million; CVS plans to create diagnostic apps; a survey shows advertising agencies plan to keep head count steady for the rest of the year
Jed Savage replaces Scott Wolf.
Tina Fascetti is the mid-sized agency's new Chief Creative Officer. CEO Matt Brown (and ICC Lowe alum) tells MM&M the new Guidemark is just getting started.
John Whyte of the Discovery Channel is the organization's new director of professional affairs and engagement.
Weber Shandwick hired Susan Smirnoff away from the healthcare practice of Ruder Finn, where she had spent more than three decades.
Amgen is buying deCODE Genetics, an Icelandic firm, for $415 million in cash.
The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society's publications, soon to be rolled up into the JAMA brand.
Stuart Arbuckle, formerly of Amgen, has been named Vertex's EVP and chief commercial officer.
Publisher Elsevier announced Monday that it will increase the number of papers it publishes for the Journal of Diabetes and Its Complications.
Novartis named Brian McNamara as division head of OTC, replacing J&J veteran Naomi Kelman, who spent a year in the role.
Publicis Healthcare Communications Group named Anders Ekman managing director of Saatchi & Saatchi Health Communications New York, the flagship professional healthcare agency of the Saatchi brand.
Two of the drug industry's brightest minds in social media, Shwen Gwee and Marc Monseau, are changing jobs, with Gwee leaving Vertex for Edelman and Monseau exiting J&J to open his own firm.
Pfizer named GSK's Dr. Yvonne Greenstreet SVP, head of medicines development for its Specialty Care Business Unit.
Lighthouse Learning, which develops and sells CME curricula without taking commercial support, hired Sherri Foster as CME director.
Market research agency Synovate Healthcare has hired Paul Villa as SVP, payer and market access research.
MedImmune named Scott Carmer EVP commercial operations, with responsibility for all sales, marketing, sales operations and global marketing functions along with commercialization of pipeline products.
Bayer HealthCare named Novartis COO Jörg Reinhardt chairman of its Bayer HealthCare AG Board of Management and Bayer Healthcare Executive Committee.
Novartis North America pharma chief Ludwig Hantson, PhD has joined specialty biopharma Baxter International as head of international operations.
Microsoft hired FDA Office of Device Evaluation director Donna-Bea Tillman.
MannKind appointed former Novartis global development head James Shannon to its board.
Lilly named former Indianapolis mayor Bart Peterson to lead its communications and corporate affairs functions.
Reuters Health hired Ivan Oransky as executive editor, heading editorial operations for the company's global medical and healthcare news services. The appointment is effective June 15.
Pfizer hired onetime Gore advisor turned healthcare think tanker Gregory Simon to head its global policy efforts as the industry gears up for a health reform fight in Washington.
Pfizer named Elizabeth Barrett regional president, US for its Oncology Business Unit, a new position, with responsibility for Pfizer's US oncology sales, field operations and marketing.
Pfizer named Kathryn Metcalfe VP, corporate reputation and policy communication - a new post in which she's tasked with building the company's reputation and communicating Pfizer's stance on policy issues worldwide.
In joint company statements today, GSK and Lilly announced that Deirdre Connelly has resigned as president of US operations at Lilly, to become president, North American pharmaceuticals, at GSK.
Chris Viehbacher is leaving GlaxoSmithKline to become CEO at Sanofi-Aventis
Medical Economics has hired five new senior-level editors, and relocated its offices to Cleveland, Ohio.
Cynthia Schwalm has been appointed president of Eisai's commercial operations in the US, effective May 5. She will report to Lonnel Coats, president and COO, Eisai Corporation of North America.
MedPoint Communications named Pamela Ring VP and senior director of account management.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.